[ad_1]
▲ BBC news reporting on allergic reactions of those who have been vaccinated against Corona 19 developed by Pfizer-Bioentech. | |
Ⓒ BBC |
See related photos |
Two people had allergic reactions in the UK, where the world’s first Pfizer-Bioentech new coronavirus (Corona 19) vaccine was started.
According to major foreign media such as AP and BBC, the British government said that two people who received the vaccine developed an allergic reaction immediately after vaccination.
These two were cared for by the National Health Service (NHS), which administers the vaccine, and reported symptoms of an anaphylactoid reaction after receiving the vaccine.
The UK’s Medicines and Healthcare Products Regulatory Authority (MHRA) then issued guidance that, during the investigation, those who had a significant allergic reaction to medicines, foods and vaccines in the past should not receive the Corona vaccine 19.
In addition, he emphasized that the vaccination site should always equip artificial cardiopulmonary resuscitation equipment in case of emergency.
Professor Stephen Foyce, NHS Medical Director, said: “Because some of the vaccines have had an allergic reaction, people with a history of allergies should not get the vaccine at this time.”
However, “allergic reactions are common in new vaccines, so preventive measures,” he added, “are both recovering well.”
Pfizer said, “Our vaccine did not raise any serious safety concerns in the phase 3 clinical trial, which is a key stage in its development,” said Pfizer. “We will support MHRA’s investigation of this allergic reaction.”
However, it was discovered that Pfizer conducted clinical trials that excluded allergic reactions from the outset.
CNN reported that Pfizer conducted a clinical trial involving 44,000 people based on data submitted to the U.S. Food and Drug Administration (FDA), but excluded those with a history of allergies due to concerns about possible side effects.
In this regard, the Secretary of Health of the United States, Alix Aza, told CNN that “we will work with the health authorities of the United Kingdom to review the data on allergic reactions to the COVID-19 vaccine.” “The FDA will not violate the principle of” I emphasized.
The UK began vaccinating the world’s first COVID-19 vaccine developed by Pfizer on the 8th, and the Canadian Ministry of Health also approved the use of the Pfizer vaccine.
Health Canada said in a statement that “(the Pfizer vaccine) is safe, effective and of good quality. We will closely monitor safety even after the vaccine is released, and will take immediate action if concerns arise.”
The United States also plans to vaccinate the Pfizer vaccine on day 10 and, if approved, will be evaluated for urgent use.